UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000008742
Receipt No. R000010267
Official scientific title of the study Studies on the effect of free radical scavenger Edaravone against postoperative hyper-perfusion syndrome after STA-MCA bypass surgery for adult moyamoya disease.
Date of disclosure of the study information 2012/08/21
Last modified on 2016/10/10 (Ver. 6)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Studies on the effect of free radical scavenger Edaravone against postoperative hyper-perfusion syndrome after STA-MCA bypass surgery for adult moyamoya disease.
Title of the study (Brief title) Studies on the effect of free radical scavenger Edaravone against postoperative hyper-perfusion syndrome after STA-MCA bypass surgery for adult moyamoya disease.
Region
Japan

Condition
Condition moyamoya disease
Classification by specialty
Neurosurgery
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To evaluate the effect of the edaravone against hyper-perfusion syndrome occuring after revascularization surgery for adult moyamoya disease. Patients who were administered edaravone prospectively is compared with the historical control group.
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1 Confirmatory
Trial characteristics_2 Pragmatic
Developmental phase Not applicable

Assessment
Primary outcomes The incidence of the hyper-perfusion syndrome within 7 days after the revasucularization surgery.
Key secondary outcomes The incidence of asymptomatic hyper-perfusion on the cerebral blood flow image within 7 days after the revascularization surgery.

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Historical
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Prevention
Type of intervention
Medicine
Interventions/Control_1 Administration of edaravone from preoperative to postoperative day 7.
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
16 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Adult patients with moyamoya disease scheduled for revascularization surgery in Hokkaido University Hospital.
Key exclusion criteria Patients with serum creatinine level is greater than 1.5mg/dL.
Patients with a history of hypersensitivity to edaravone.
Patients determined to be ineligible to doctor due to a problem with the general condition.
Target sample size 32

Research contact person
Name of lead principal investigator Kiyohiro Houkin
Organization Hokkaido University Hospital
Division name Department of Neurosurgery
Address North-15, West-7, Kita-ku, Sapporo, Japan
TEL 011-706-5987
Email houkin@med.hokudai.ac.jp

Public contact
Name of contact person Naoki Nakayama
Organization Hokkaido University Hospital
Division name Department of Neurosurgery
Address North-15, West-7, Kita-ku, Sapporo, Japan
TEL 011-706-5987
Homepage URL
Email naoki-na@med.hokudai.ac.jp

Sponsor
Institute Department of Neurosurgery, Hokkaido University Graduate School of Medicine
Institute
Department

Funding Source
Organization Department of Neurosurgery, Hokkaido University Graduate School of Medicine
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2012 Year 08 Month 21 Day

Progress
Recruitment status Completed
Date of protocol fixation
2012 Year 07 Month 03 Day
Anticipated trial start date
2012 Year 09 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2012 Year 08 Month 21 Day
Last modified on
2016 Year 10 Month 10 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000010267